Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to -$13.8 million.

  • Haemonetics' Change in Inventory fell 17985.81% to -$13.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$38.5 million, marking a year-over-year decrease of 14605.04%. This contributed to the annual value of $64.7 million for FY2025, which is 773.05% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Change in Inventory is -$13.8 million, which was down 17985.81% from -$21.8 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Change in Inventory registered a high of $36.2 million during Q2 2024, and its lowest value of -$21.8 million during Q3 2025.
  • Over the past 5 years, Haemonetics' median Change in Inventory value was $1.4 million (recorded in 2022), while the average stood at $1.8 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first crashed by 57413.91% in 2022, then skyrocketed by 75691.57% in 2024.
  • Quarter analysis of 5 years shows Haemonetics' Change in Inventory stood at -$3.1 million in 2021, then soared by 148.21% to $1.5 million in 2022, then surged by 578.37% to $10.1 million in 2023, then skyrocketed by 72.17% to $17.3 million in 2024, then crashed by 179.86% to -$13.8 million in 2025.
  • Its last three reported values are -$13.8 million in Q4 2025, -$21.8 million for Q3 2025, and -$3.3 million during Q2 2025.